Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations

Viral vectors have been widely investigated as tools for cancer immunotherapy. Although many preclinical studies demonstrate significant virus-mediated tumour inhibition in synergy with immune checkpoint molecules and other drugs, the clinical success of viral vector applications in cancer therapy c...

Descripción completa

Detalles Bibliográficos
Autores principales: Spunde, Karina, Korotkaja, Ksenija, Zajakina, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495732/
https://www.ncbi.nlm.nih.gov/pubmed/36140243
http://dx.doi.org/10.3390/biomedicines10092142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495732/
https://www.ncbi.nlm.nih.gov/pubmed/36140243
http://dx.doi.org/10.3390/biomedicines10092142

Ejemplares similares